查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1140148

膽鹼酒石酸氫鹽市場：按類型（DL、D、L）、按應用（藥物和膳食補充劑、食品和飲料、嬰兒食品等）-全球機會分析和行業預測，2021-2031

Choline bitartrate Market By Type (DL, D, L), By Application (Pharmaceutical and Nutritional Supplement, Food and beverage, Baby Food, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 255 Pages | 商品交期: 2-3個工作天內

價格

全球酒石酸氫膽鹼市場預計將在 2021 年達到 4.102 億美元，在 2031 年達到 7.362 億美元，從 2022 年到 2031 年的複合年增長率為 6.1%。

酒石酸氫膽鹼是一種活性藥物成分，由酒石酸和膽鹼的混合物製成。它比純膽鹼吸收更好，並且有兩種廣泛可用的形式：l-膽鹼酒石酸氫鹽和 dl-酒石酸氫鹽膽鹼。它在脂質運輸、健康新陳代謝、細胞膜支持、DNA 合成和早期大腦發育中發揮重要作用。它用於生產有機和增強型有機嬰兒食品，因為它可以增強兒童的視覺空間記憶。它還用於解決各種健康問題，廣泛用於家禽和動物飼料、嬰兒食品、藥品和膳食補充劑、食品和飲料。

近年來，由於嬰兒潮一代人口的激增、快速的城市化進程、發展中國家人民可支配收入的增加以及女性勞動力參與度的增加，對嬰兒配方奶粉的需求有所增加。根據 Vitafoods Insights 的數據，嬰兒配方奶粉的銷售額預計將通過電子商務實現顯著增長，初創配方奶粉預計將佔全球需求的 45% 左右。嬰兒配方奶粉的銷量將繼續增長，因為它們被認為是母乳的可行替代品。此外，預計從 2019 年到 2026 年，全球嬰兒配方奶粉市場將以 10% 的複合年增長率顯著增長。此外，根據美國農業部 (AMS USDA) 的農業營銷服務局 (AMS USDA)，膽鹼鹽被列入食品和藥物法規 (B.25.054(1)(a)(vii)) 的第 25 部分，並獲准使用在加拿大的嬰兒中。允許在牛奶中。有機生產系統一般原則和治理標準 (CAN/CGSB-32.310-2006) 和有機生產系統允許物質清單 (CAN/CGSB-32.311-2006) 禁止膽鹼鹽在這些食品中的法律要求是必需的。對於他們的有機同行來說是可以接受的。此外，根據歐盟委員會指令 2006/141/EC、歐盟委員會指令 2006/125/EC，膽鹼鹽是歐盟允許在嬰兒配方奶粉和嬰兒食品中使用的膽鹼形式。它也被允許在“特定營養用途食品”類別中（委員會條例 953/2009，委員會指令 2009/39/EC）。根據歐盟委員會條例 889/2008 的法律要求，這些食品的有機對應物中允許使用膽鹼鹽。因此，預計在預測期內，對嬰兒配方奶粉的需求增加將推動對酒石酸膽鹼的需求。然而，對天然食品的日益偏好和對嬰兒配方奶粉生產的嚴格監管可能會阻礙市場的穩定增長。然而，擴大酒石酸氫膽鹼在醫療保健中的應用以治療多種疾病以及在家禽和動物飼料中的應用，預計將為酒石酸氫膽鹼市場的增長創造有利可圖的機會。

膽鹼酒石酸氫鹽市場分為類型、應用和區域。按類型分為DL、D、L。按用途分為藥品/膳食補充劑、食品/飲料、嬰兒食品等。按地區劃分，分析分為北美、歐洲、亞太地區和LAMEA。在這些地區中，由於對嬰兒食品和嬰兒配方奶粉產品的需求增加，北美將在 2021 年佔全球酒石酸氫膽鹼市場的最高份額。此外，由於忙碌的日常生活和消費者的壓力水平，營養補充劑的銷售量預計將在預測期內推動苦味膽鹼市場的增長。

在全球酒石酸氫膽鹼市場運營的主要公司有 Balchem Inc.、Celtic Chemicals Ltd、Cepham Life Sciences、Fengchen Group Co.,Ltd、Glentham Life Sciences Ltd、MP Biomedicals、Nutragreenlife Biotechnology Co. Ltd、NutriScience Innovations, LLC、Tokyo Chemical Industry Co., Ltd.。這些公司正在通過產品發布、合資企業、合作夥伴關係和產能擴張來爭奪市場份額，以滿足預測期內未來的酒石酸氫膽鹼市場需求。

目錄

第 1 章 簡介

第二章執行摘要

第三章市場概況

  • 市場定義和範圍
  • 主要發現
    • 主要投資口袋
  • 波特五力分析
  • 大公司定位
  • 市場動態
    • 促進者
    • 抑製劑
    • 機會
  • COVID-19 影響分析
  • 專利情況
  • 價值鏈分析

4 膽鹼酒石酸氫鹽市場，按類型

  • 概述
    • 市場規模和預測
  • 深度學習
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：國家分析
  • D.
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • L.
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類

5 膽鹼酒石酸氫鹽市場，按應用

  • 概述
    • 市場規模和預測
  • 藥品、膳食補充劑
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • 飲食
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • B：按食物
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類

6. 按地區分列的酒石酸氫膽鹼市場

  • 概述
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按應用
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按應用
    • 歐洲市場規模和預測：按國家分類
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 意大利
      • 歐洲其他地區
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按類型
    • 亞太市場規模和應用預測
    • 亞太市場規模和預測：按國家分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳大利亞
      • 亞太其他地區
  • 拉美亞
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按應用
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非共和國
      • 其餘的 LAMEA

第七章 公司情況

  • 介紹
  • 關鍵成功策略
  • 10大公司產品圖
  • 比賽儀表板
  • 比賽熱圖
  • 重大發展

第八章公司簡介

  • Balchem Inc.
  • Celtic Chemicals Ltd
  • Cepham Life Sciences
  • Fengchen Group Co.,Ltd
  • Glentham Life Sciences Ltd
  • MP Biomedicals
  • Nutragreenlife Biotechnology Co.,Ltd
  • NutriScience Innovations, LLC
  • Puyer Group
  • TOKYO CHEMICAL INDUSTRY CO., LTD.
Product Code: A17003

The global choline bitartrate market was valued at $410.2 million in 2021, and is projected to reach $736.2 million by 2031, registering a CAGR of 6.1% from 2022 to 2031.

Choline bitartrate is an active pharmaceutical ingredient produced from a mixture of tartaric acid and choline. It has a better absorption rate than pure choline and is widely available in two different types such choline l-bitartrate and choline dl-bitartrate. It plays a crucial role in lipid transportation, healthy metabolism, supports cell membrane, DNA synthesis, and early brain development. It is utilized in producing organic and fortified organic baby foods as they enhance visuospatial memory in a child. It is used in various health-related problem and is widely used in poultry and animal feed, baby food, pharmaceutical & nutritional supplement, and food & beverage.

In recent years, there is rising demand for infant formula due to the surge in the baby boomers population, rapid urbanization, rising disposable income of people in developing countries, and increasing female participation in the labor force. According to Vitafoods Insights, infant formula sales is predicted to witness substantial growth via e-commerce, and starting milk formulas are anticipated to hold around 45% of global demand. Infant formula sales will continue to grow due to its growing acceptance as a viable breastmilk alternative. Further, during 2019-2026, the global infant formula market is projected for noteworthy growth at a 10% CAGR. Moreover, according to Agricultural Marketing Service U.S. DEPARTMENT OF AGRICULTURE (AMS USDA), choline salts are allowable in infant formula in Canada, listed under Division 25 (B.25.054(1)(a)(vii)) of the Food and Drug Regulations. Choline salts are allowable in organic counterparts of these food products by virtue of their necessity by legal requirement, according to Organic Production Systems General Principles and Management Standards (CAN/CGSB-32.310-2006) and Organic Production Systems Permitted Substances List (CAN/CGSB-32.311-2006). Further, choline salts are an acceptable form of choline in infant formula and baby food in European Union, according to Commission Directive 2006/141/EC, Commission Directive 2006/125/EC.  They are also allowed in the category of "foods for particular nutritional uses" (Commission Regulation 953/2009, Commission Directive 2009/39/EC).   Choline salts are allowable in organic counterparts of these food products by virtue of their necessity by legal requirement, according to European Commission Regulation 889/2008. Thus, the growing demand for infant formula is anticipated to propel the demand for choline bitartrate during the forecast period. However, growing inclination towards natural food products and stringent regulation for manufacturing infant formula may hamper the steady growth of the market. Nonetheless, the growing use of choline bitartrate in healthcare to treat numerous diseases and its use in poultry and animal feed is anticipated to create lucrative opportunities for the growth of the choline bitartrate market.

The choline bitartrate market is classified into type, application, and region. On the basis of type, the market is segmented into DL, D, and L. On the basis of application, the market is divided into pharmaceutical & nutritional supplement, food & beverage, baby food, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the regions, North America held the highest share of the global choline bitartrate market in 2021 owing to increase in demand for baby food and infant formula products. Further, the rise in sales of dietary supplements owing to the hectic routines and stress level of the consumers is anticipated to propel the choline bitartrate market growth during the forecast period.

The key players operating in the global choline bitartrate market include Balchem Inc.; Celtic Chemicals Ltd; Cepham Life Sciences; Fengchen Group Co.,Ltd; Glentham Life Sciences Ltd; MP Biomedicals; Nutragreenlife Biotechnology Co.,Ltd; NutriScience Innovations, LLC; Puyer Group; and TOKYO CHEMICAL INDUSTRY CO., LTD. These companies compete for the share of the market through product launch, joint venture, partnership, and expansion of the production capabilities to meet the future demand for the choline bitartrate market during the forecast period.     

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the choline bitartrate market analysis from 2021 to 2031 to identify the prevailing choline bitartrate market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the choline bitartrate market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global choline bitartrate market trends, key players, market segments, application areas, and market growth strategies.

             

Key Market Segments

By Type

  • DL
  • D
  • L

By Application

  • Baby Food
  • Others
  • Pharmaceutical and Nutritional Supplement
  • Food and beverage

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Rest of LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
  • Key Market Players
    • Balchem Inc.
    • Celtic Chemicals Ltd
    • Cepham Life Sciences
    • Fengchen Group Co.,Ltd
    • Glentham Life Sciences Ltd
    • MP Biomedicals
    • Nutragreenlife Biotechnology Co.,Ltd
    • NutriScience Innovations, LLC
    • Puyer Group
    • TOKYO CHEMICAL INDUSTRY CO., LTD.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape
  • 3.8.Value Chain Analysis

CHAPTER 4: CHOLINE BITARTRATE MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 DL
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 D
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 L
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: CHOLINE BITARTRATE MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Pharmaceutical and Nutritional Supplement
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Food and beverage
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Baby Food
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: CHOLINE BITARTRATE MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Type
    • 6.2.3 North America Market size and forecast, by Application
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Type
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Type
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Type
      • 6.2.4.3.2 Market size and forecast, by Application
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Type
    • 6.3.3 Europe Market size and forecast, by Application
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Type
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Type
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.3 U.K.
      • 6.3.4.3.1 Market size and forecast, by Type
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.4 Spain
      • 6.3.4.4.1 Market size and forecast, by Type
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.5 Italy
      • 6.3.4.5.1 Market size and forecast, by Type
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Type
      • 6.3.4.6.2 Market size and forecast, by Application
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Type
    • 6.4.3 Asia-Pacific Market size and forecast, by Application
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 China
      • 6.4.4.1.1 Market size and forecast, by Type
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.2 Japan
      • 6.4.4.2.1 Market size and forecast, by Type
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.3 India
      • 6.4.4.3.1 Market size and forecast, by Type
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.4 South Korea
      • 6.4.4.4.1 Market size and forecast, by Type
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.5 Australia
      • 6.4.4.5.1 Market size and forecast, by Type
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Type
      • 6.4.4.6.2 Market size and forecast, by Application
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Type
    • 6.5.3 LAMEA Market size and forecast, by Application
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Type
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Type
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Type
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Type
      • 6.5.4.4.2 Market size and forecast, by Application

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Balchem Inc.
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Celtic Chemicals Ltd
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Cepham Life Sciences
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Fengchen Group Co.,Ltd
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Glentham Life Sciences Ltd
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 MP Biomedicals
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Nutragreenlife Biotechnology Co.,Ltd
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 NutriScience Innovations, LLC
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Puyer Group
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 TOKYO CHEMICAL INDUSTRY CO., LTD.
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. CHOLINE BITARTRATE MARKET SIZE, FOR DL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. CHOLINE BITARTRATE MARKET FOR DL BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. CHOLINE BITARTRATE MARKET SIZE, FOR D, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. CHOLINE BITARTRATE MARKET FOR D BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. CHOLINE BITARTRATE MARKET SIZE, FOR L, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. CHOLINE BITARTRATE MARKET FOR L BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 9. CHOLINE BITARTRATE MARKET SIZE, FOR PHARMACEUTICAL AND NUTRITIONAL SUPPLEMENT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. CHOLINE BITARTRATE MARKET FOR PHARMACEUTICAL AND NUTRITIONAL SUPPLEMENT BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. CHOLINE BITARTRATE MARKET SIZE, FOR FOOD AND BEVERAGE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. CHOLINE BITARTRATE MARKET FOR FOOD AND BEVERAGE BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. CHOLINE BITARTRATE MARKET SIZE, FOR BABY FOOD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. CHOLINE BITARTRATE MARKET FOR BABY FOOD BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. CHOLINE BITARTRATE MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. CHOLINE BITARTRATE MARKET FOR OTHERS BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. CHOLINE BITARTRATE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. U.S. CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 22. U.S. CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 23. CANADA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 24. CANADA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 25. MEXICO CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 26. MEXICO CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 27. EUROPE CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. EUROPE CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 29. EUROPE CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 30. GERMANY CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 31. GERMANY CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. FRANCE CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. FRANCE CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. U.K. CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. U.K. CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. SPAIN CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 37. SPAIN CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. ITALY CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. ITALY CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 40. REST OF EUROPE CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. REST OF EUROPE CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. CHINA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. CHINA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. JAPAN CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 48. JAPAN CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 49. INDIA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. INDIA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. SOUTH KOREA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. SOUTH KOREA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. AUSTRALIA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 54. AUSTRALIA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 55. REST OF ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. REST OF ASIA-PACIFIC CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. LAMEA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. LAMEA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. LAMEA CHOLINE BITARTRATE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 60. BRAZIL CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. BRAZIL CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. SAUDI ARABIA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. SAUDI ARABIA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 64. SOUTH AFRICA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. SOUTH AFRICA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. REST OF LAMEA CHOLINE BITARTRATE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 67. REST OF LAMEA CHOLINE BITARTRATE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 68.BALCHEM INC.: COMPANY SNAPSHOT
  • TABLE 69.BALCHEM INC.: OPERATING SEGMENTS
  • TABLE 70.BALCHEM INC.: PRODUCT PORTFOLIO
  • TABLE 71.BALCHEM INC.: NET SALES,
  • TABLE 72.BALCHEM INC.: KEY STRATERGIES
  • TABLE 73.CELTIC CHEMICALS LTD: COMPANY SNAPSHOT
  • TABLE 74.CELTIC CHEMICALS LTD: OPERATING SEGMENTS
  • TABLE 75.CELTIC CHEMICALS LTD: PRODUCT PORTFOLIO
  • TABLE 76.CELTIC CHEMICALS LTD: NET SALES,
  • TABLE 77.CELTIC CHEMICALS LTD: KEY STRATERGIES
  • TABLE 78.CEPHAM LIFE SCIENCES: COMPANY SNAPSHOT
  • TABLE 79.CEPHAM LIFE SCIENCES: OPERATING SEGMENTS
  • TABLE 80.CEPHAM LIFE SCIENCES: PRODUCT PORTFOLIO
  • TABLE 81.CEPHAM LIFE SCIENCES: NET SALES,
  • TABLE 82.CEPHAM LIFE SCIENCES: KEY STRATERGIES
  • TABLE 83.FENGCHEN GROUP CO.,LTD: COMPANY SNAPSHOT
  • TABLE 84.FENGCHEN GROUP CO.,LTD: OPERATING SEGMENTS
  • TABLE 85.FENGCHEN GROUP CO.,LTD: PRODUCT PORTFOLIO
  • TABLE 86.FENGCHEN GROUP CO.,LTD: NET SALES,
  • TABLE 87.FENGCHEN GROUP CO.,LTD: KEY STRATERGIES
  • TABLE 88.GLENTHAM LIFE SCIENCES LTD: COMPANY SNAPSHOT
  • TABLE 89.GLENTHAM LIFE SCIENCES LTD: OPERATING SEGMENTS
  • TABLE 90.GLENTHAM LIFE SCIENCES LTD: PRODUCT PORTFOLIO
  • TABLE 91.GLENTHAM LIFE SCIENCES LTD: NET SALES,
  • TABLE 92.GLENTHAM LIFE SCIENCES LTD: KEY STRATERGIES
  • TABLE 93.MP BIOMEDICALS: COMPANY SNAPSHOT
  • TABLE 94.MP BIOMEDICALS: OPERATING SEGMENTS
  • TABLE 95.MP BIOMEDICALS: PRODUCT PORTFOLIO
  • TABLE 96.MP BIOMEDICALS: NET SALES,
  • TABLE 97.MP BIOMEDICALS: KEY STRATERGIES
  • TABLE 98.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: COMPANY SNAPSHOT
  • TABLE 99.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: OPERATING SEGMENTS
  • TABLE 100.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: PRODUCT PORTFOLIO
  • TABLE 101.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: NET SALES,
  • TABLE 102.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD: KEY STRATERGIES
  • TABLE 103.NUTRISCIENCE INNOVATIONS, LLC: COMPANY SNAPSHOT
  • TABLE 104.NUTRISCIENCE INNOVATIONS, LLC: OPERATING SEGMENTS
  • TABLE 105.NUTRISCIENCE INNOVATIONS, LLC: PRODUCT PORTFOLIO
  • TABLE 106.NUTRISCIENCE INNOVATIONS, LLC: NET SALES,
  • TABLE 107.NUTRISCIENCE INNOVATIONS, LLC: KEY STRATERGIES
  • TABLE 108.PUYER GROUP: COMPANY SNAPSHOT
  • TABLE 109.PUYER GROUP: OPERATING SEGMENTS
  • TABLE 110.PUYER GROUP: PRODUCT PORTFOLIO
  • TABLE 111.PUYER GROUP: NET SALES,
  • TABLE 112.PUYER GROUP: KEY STRATERGIES
  • TABLE 113.TOKYO CHEMICAL INDUSTRY CO., LTD.: COMPANY SNAPSHOT
  • TABLE 114.TOKYO CHEMICAL INDUSTRY CO., LTD.: OPERATING SEGMENTS
  • TABLE 115.TOKYO CHEMICAL INDUSTRY CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 116.TOKYO CHEMICAL INDUSTRY CO., LTD.: NET SALES,
  • TABLE 117.TOKYO CHEMICAL INDUSTRY CO., LTD.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CHOLINE BITARTRATE MARKET SEGMENTATION
  • FIGURE 2.CHOLINE BITARTRATE MARKET,2021-2031
  • FIGURE 3.CHOLINE BITARTRATE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CHOLINE BITARTRATE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATENT ANALYSIS BY COMPANY
  • FIGURE 13.PATENT ANALYSIS BY COUNTRY
  • FIGURE 14.VALUE CHAIN ANALYSIS
  • FIGURE 15.CHOLINE BITARTRATE MARKET,BY TYPE,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DL CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF D CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF L CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 19.CHOLINE BITARTRATE MARKET,BY APPLICATION,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND NUTRITIONAL SUPPLEMENT CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF FOOD AND BEVERAGE CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BABY FOOD CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS CHOLINE BITARTRATE MARKET,2021-2031(%)
  • FIGURE 24.CHOLINE BITARTRATE MARKET BY REGION,2021
  • FIGURE 25.U.S. CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 26.CANADA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 27.MEXICO CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 28.GERMANY CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 29.FRANCE CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 30.U.K. CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 31.SPAIN CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 32.ITALY CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 33.REST OF EUROPE CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 34.CHINA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 35.JAPAN CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 36.INDIA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 37.SOUTH KOREA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF ASIA-PACIFIC CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 40.BRAZIL CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 41.SAUDI ARABIA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 42.SOUTH AFRICA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 43.REST OF LAMEA CHOLINE BITARTRATE MARKET,2021-2031($MILLION)
  • FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 47.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 48.COMPETITIVE DASHBOARD
  • FIGURE 49.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 50.BALCHEM INC..: NET SALES ,($MILLION)
  • FIGURE 51.CELTIC CHEMICALS LTD.: NET SALES ,($MILLION)
  • FIGURE 52.CEPHAM LIFE SCIENCES.: NET SALES ,($MILLION)
  • FIGURE 53.FENGCHEN GROUP CO.,LTD.: NET SALES ,($MILLION)
  • FIGURE 54.GLENTHAM LIFE SCIENCES LTD.: NET SALES ,($MILLION)
  • FIGURE 55.MP BIOMEDICALS.: NET SALES ,($MILLION)
  • FIGURE 56.NUTRAGREENLIFE BIOTECHNOLOGY CO.,LTD.: NET SALES ,($MILLION)
  • FIGURE 57.NUTRISCIENCE INNOVATIONS, LLC.: NET SALES ,($MILLION)
  • FIGURE 58.PUYER GROUP.: NET SALES ,($MILLION)
  • FIGURE 59.TOKYO CHEMICAL INDUSTRY CO., LTD..: NET SALES ,($MILLION)